Dr. Oscar Xu

Oncology pharmacist · IEO Milano · Italy (IT) · Oncology

Tier 3STK-0064Needs reviewOwner MSL MTMei Tanaka

Data minimisation

Consent status: Recorded. The name shown may be a pseudonym. Contact details, personal identifiers and remuneration fields are hidden for your role; only scientific-profile fields needed for engagement planning are displayed.

Specialty: Thoracic oncology
Disease interests: NSCLC
Scientific interests: Elderly patientsPD-L1 biomarkers
Engagement preference: Either
Advisory boards: 1
Publications: 14
Source system: Veeva CRM
Data quality: Needs review

Engagement plan

Cadence target for Tier 3: 1 per year (assumption)

Last engaged: 07 Jun 2026 (100 days ago)
Next planned contact: 07 Jun 2027
Last 6 months vs target: 100%
1 of 1 expected engagements

Insights from this stakeholder (0)

No insights captured from engagements with this stakeholder.

Engagement history (1)

All engagements including drafts, newest first

Date	Type	Format	MSL	Product	Topics	Insights	Flags	Status
07 Jun 2026	Scientific exchange	Phone	Mei Tanaka	Vantrexa	Elderly / ECOG 2 patientsBrain-metastasis subgroup data	0	—	Reviewed	ENG-0027

Timeline

07 Jun 2026
Scientific exchange
Elderly / ECOG 2 patients, Brain-metastasis subgroup data

Related stakeholders (4)

IEO Milano

Dr. Emiko Olsen
Thoracic medical oncologist
Tier 2
Dr. Mariana Sato
General neurologist
Tier 1
Dr. Ximena Olsen
Primary care physician
Tier 2
Dr. Zoë Vogel
General neurologist
Tier 2